Literature DB >> 2839458

Clinical features and current management of chronic granulomatous disease.

C B Forrest1, J R Forehand, R A Axtell, R L Roberts, R B Johnston.   

Abstract

Chronic granulomatous disease (CGD) is a diverse disorder characterized by several clinical presentations and a multitude of metabolic defects. The authors summarize the clinical features and current management of CGD, offer a definition of the disease based on molecular defects of the respiratory burst, and present their experience with trimethoprim/sulfamethoxazole prophylaxis.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2839458

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  15 in total

Review 1.  Neutrophil disorders and their management.

Authors:  R Lakshman; A Finn
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  A novel polymorphism in the coding region of CYBB, the human gp91-phox gene.

Authors:  F Kuribayashi; M de Boer; J H Leusen; A J Verhoeven; D Roos
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

3.  X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase.

Authors:  J Rae; P E Newburger; M C Dinauer; D Noack; P J Hopkins; R Kuruto; J T Curnutte
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

4.  Hepatic abscess in patients with chronic granulomatous disease.

Authors:  Matthew Lublin; David L Bartlett; David N Danforth; Howard Kauffman; John I Gallin; Harry L Malech; Thomas Shawker; Peter Choyke; David E Kleiner; Douglas J Schwartzentruber; Richard Chang; Ellen S DeCarlo; Steven M Holland
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

5.  The cytosolic subunit p67phox contains an NADPH-binding site that participates in catalysis by the leukocyte NADPH oxidase.

Authors:  R M Smith; J A Connor; L M Chen; B M Babior
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

Review 6.  New perspectives in chronic granulomatous disease.

Authors:  R A Ezekowitz; P E Newburger
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

7.  Enhancement of normal neutrophil chemiluminescence by chronic granulomatous disease neutrophils.

Authors:  R L Roberts; B J Ank; E R Stiehm
Journal:  Inflammation       Date:  1989-12       Impact factor: 4.092

8.  Mutations in the promoter region of the gene for gp91-phox in X-linked chronic granulomatous disease with decreased expression of cytochrome b558.

Authors:  P E Newburger; D G Skalnik; P J Hopkins; E A Eklund; J T Curnutte
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

9.  Resolution of hepatic abscess after interferon gamma in chronic granulomatous disease.

Authors:  R A Hague; E J Eastham; R E Lee; A J Cant
Journal:  Arch Dis Child       Date:  1993-10       Impact factor: 3.791

Review 10.  Chronic granulomatous disease 100% corrected by displacement bone marrow transplantation from a volunteer unrelated donor.

Authors:  J R Hobbs; M Monteil; D R McCluskey; E Jurges; M el Tumi
Journal:  Eur J Pediatr       Date:  1992-11       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.